The effect of treatment of non-alcoholic fatty liver with zucchini in pregnant women on the gestational diabetes
Design
In this randomized clinical trial, 60 consecutive pregnant women with non-alcoholic fatty liver, were randomly divided into 2 groups of intervention and control
Settings and conduct
In this randomized clinical trial , 60 consecutive pregnant women with non-alcoholic fatty liverattending to Kosar Obstetrics Clinic in Arak were enrolled. They were randomly divided into 2 groups of intervention and control. The first group received zucchini 100 gr daily plus dietary regimen for 6 weeks and the control group received just dietary regimen
Participants/Inclusion and exclusion criteria
Inclusion criteria: Known cases of non-alcoholic fatty liverwomen with age between 20-35 years.
Exclusion: Alcohol users, other chronic hepatic diseases, known cases of Diabetes mellitus under medical treatment
Intervention groups
In Intervention group they used zucchini 100 gram daily plus dietary regimen for 6 weeks and in control group they were just under dietary regimen
The effect of treatment of non-alcoholic fatty liver with zucchini in pregnant women on the gestational diabetes
Public title
The effect of treatment of non-alcoholic fatty liver with zucchini in pregnant women on the gestational Diabetes
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age between 20-35 years old
Known case of non-alcoholic fatty liver
Exclusion criteria:
Alcohol user
Known cases of autoimmune hepatitis, Hepatitis B, Hepatitis C, or other chronic hepatic diseases
Known cases of Diabetic Mellitus under treatment
Patients who use Vitamin C, Zinc, Mn or the other antioxidants
Patients who use Fibrate, Statins, NSAIDs, Amiodarone or Tamoxifen
Age
From 20 years old to 35 years old
Gender
Female
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
60
Randomization (investigator's opinion)
Randomized
Randomization description
Simple individual randomization; randomization with envelopes and allocating into two groups A and B.
In this method, we select a number of cards or letters as an intervention group and the same number of cards for the control group, then the cards are mixed. One card is taken out and its allocation is registered and the card is returned to the box near other cards. Then the cards are mixed again and we take out another card. This process continues to reach a random sequence according to sample size.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics comittee of Arak University of Medical Sciences